KRAS and adenocarcinoma: Adenocarcinoma and signet ring cell carcinoma (Kras, Ki67 and caspase-3 expression; IFN-γ, IL-1β, IL-8, TGF-β, TNF-α and IL-6; Wnt-Apc-β-catenin pathway)